Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development

 
Thumbnail
View/Open
Author
Hellström, Ann
Ley, David
Hansen‐Pupp, Ingrid
Hallberg, Boubou
Löfqvist, Chatarina
van Weissenbruch, Mirjam
Ramenghi, Luca A.
Beardsall, Kathryn
Dunger, David
Hård, Anna‐Lena
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1111/apa.13350
Metadata
Show full item record
Citation
Hellström, A., D. Ley, I. Hansen‐Pupp, B. Hallberg, C. Löfqvist, L. van Marter, M. van Weissenbruch, et al. 2016. “Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development.” Acta Paediatrica (Oslo, Norway : 1992) 105 (6): 576-586. doi:10.1111/apa.13350. http://dx.doi.org/10.1111/apa.13350.
Abstract
Abstract Poor postnatal growth after preterm birth does not match the normal rapid growth in utero and is associated with preterm morbidities. Insulin‐like growth factor 1 (IGF‐1) axis is the major hormonal mediator of growth in utero, and levels of IGF‐1 are often very low after preterm birth. We reviewed the role of IGF‐1 in foetal development and the corresponding preterm perinatal period to highlight the potential clinical importance of IGF‐1 deficiency in preterm morbidities. Conclusion: There is a rationale for clinical trials to evaluate the potential benefits of IGF‐1 replacement in very preterm infants.
Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069563/pdf/
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:29626052

Collections